Dystrophin antibody (AA 114-263)
Quick Overview for Dystrophin antibody (AA 114-263) (ABIN7870180)
Target
See all Dystrophin (DMD) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 114-263
-
Purpose
- Dystrophin Antibody / DMD
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Amino acids 114-263 from the human protein were used as the immunogen for the Dystrophin antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
-
Optimal dilution of the Dystrophin antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Prediluted in 1X PBS, 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide, *For IHC use only*
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the Dystrophin antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Dystrophin (DMD)
-
Alternative Name
- Dystrophin
-
Background
- The DMD gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [RefSeq]
-
UniProt
- P11532
-
Pathways
- Skeletal Muscle Fiber Development
Target
-